🔴 Pacific Biosciences is trading 10.98% down today with biotech-sector weakness a likely factor

Pacific Biosciences is trading 10.98% lower at $2.56, with biotech-sector weakness a likely contributor but no clear company-specific negative catalyst identified. - The XBI is down 2.50%, while major U.S. indices are higher; Pacific Biosciences’ decline is substantially larger than the sector drop. - On October 6, the company announced a TychoBio collaboration to generate RNA-sequencing data for rare-disease therapy models; available reporting does not link it to the decline.